UPC Analytics
DEEN
Übersicht · Eingereicht:

ORD_63909/2024

REMOTE MONITORING OF ANALYTE MEASUREMENTS

Prozessuale & UnteranträgeVerfahrensführungsanordnungenParis LDGeneric Order
Parteien

Kläger

Vertreter: Anne-Charlotte le Bihan (Bird & Bird AARPI); Laurent Labatte (Bird & Bird AARPI); David Sproston (Hoffmann Eitle); Mark Jones (Hoffmann Eitle)

Beklagte

Vertreter: Christian Dekoninck (Taylor Wessing N.V.); François Pochart (August Debouzy)
Richter

Französische Kammer — Einzelrichter anonymisiert.

  • Panel member (anonymized)Judge-Rapporteur
Patente
  • EP3831282
CPC-Codes: A61B5/7282, A61B5/7465, G16H40/20, H04L67/12, G16H50/70, A61B5/145, G16H40/63, G16H50/20, A61B5/0015, A61B5/0004, A61B5/14532, A61B5/14546

Sektor: Healthcare Informatics

Ausgang
Nichtig erklärt
Eingereicht:
Erste Entscheidung: 11. Dez. 2024
Sprache:

Decision on the merits from the Paris Local Division (UPC_CFI_395/2023) delivered on 11 December 2024 in DexCom's infringement action against Abbott entities concerning EP 3 831 282. The Court found the patent invalid in its entirety — neither as granted nor as amended by auxiliary requests 1, 2 or 3 — due to added subject-matter under Art. 138(1)(c) EPC. The infringement action was dismissed for lack of legal basis. DexCom was ordered to bear Abbott's costs, with the amount to be determined in separate proceedings.

Ansprüche
Streitig1
Nichtig erklärtall
Hinweise: Paris Local Division revoked EP 3 831 282 entirely for added matter; claim 1 as granted and as amended per AR1, AR2, AR3 all failed; infringement action dismissed for lack of legal basis.